Abstract
The study of Steffens et al. investigating the influence of body composition on outcomes in metastatic renal cell cancer patients, published in this issue of The Oncologist, is reviewed.
MeSH terms
-
Angiogenesis Inhibitors / therapeutic use*
-
Carcinoma, Renal Cell / drug therapy*
-
Female
-
Humans
-
Kidney Neoplasms / drug therapy*
-
Male
-
Obesity / pathology*
-
Vascular Endothelial Growth Factor A / antagonists & inhibitors*
Substances
-
Angiogenesis Inhibitors
-
VEGFA protein, human
-
Vascular Endothelial Growth Factor A